J0211 – Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0211
- Long description
- Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- Short description
- Inj, nithiodote, 3mg / 125mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2024
- Last change
- July 1, 2024 – No change
Frequently asked questions
What is HCPCS code J0211?
J0211 is a HCPCS Level II code for injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote).
Does Medicare cover J0211?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0200 – Injection, alatrofloxacin mesylate, 100 mg
- J0202 – Injection, alemtuzumab, 1 mg
- J0205 – Injection, alglucerase, per 10 units
- J0206 – Injection, allopurinol sodium, 1 mg
- J0207 – Injection, amifostine, 500 mg
- J0208 – Injection, sodium thiosulfate (pedmark), 100 mg
- J0209 – Injection, sodium thiosulfate (hope), 100 mg
- J0210 – Injection, methyldopate hcl, up to 250 mg
- J0215 – Injection, alefacept, 0.5 mg
- J0216 – Injection, alfentanil hydrochloride, 500 micrograms
- J0217 – Injection, velmanase alfa-tycv, 1 mg
- J0218 – Injection, olipudase alfa-rpcp, 1 mg
- J0219 – Injection, avalglucosidase alfa-ngpt, 4 mg
- J0220 – Injection, alglucosidase alfa, 10 mg, not otherwise specified
- J0221 – Injection, alglucosidase alfa, (lumizyme), 10 mg
- J0222 – Injection, patisiran, 0.1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.